Search

The authorizing legislation 1 for this work is in Section 937(f)--BUILDING DATA FOR RESEARCH.—

Assistant Secretary for Planning and Evaluation (ASPE) Agency for Healthcare Research and Quality (AHRQ) Assistant Secretary for Preparedness and Response (ASPR)      Centers for Disease Control and Prevention (CDC) Centers for Medicare and Medicaid Services (CMS) Chief Technology Officer (CTO) Food and Drug Administration (FDA)

The OS PCORTF Leadership Council has endorsed a strategic framework to guide OS PCORTF investments. This framework includes the following component types: 1) Standards; 2) Services; 3) Policies; 4) Governance Structures; and 5) Federal Data.  These component types, which help build research data capacity , are described below.

If you have questions or comments, you can send them to us: Postal Mail Assistant Secretary for Planning and Evaluation, Room 415F U.S. Department of Health and Human Services 200 Independence Avenue, SW Washington, DC 20201 Please be aware that postal mail sent to us takes additional time to process because of security procedures. Key Staf

Go back to the form

The Office of Health Policy consistently works with the Health Resources and Services Administration (HRSA) and HIV/AIDS stakeholders to develop nuanced understandings of issues effecting access to health care services for people living with HIV and AIDS. The office has lead several studies to assess the Ryan White Program in the context of health

Evaluation and analysis provide essential evidence for HHS to understand how its programs work, for whom, and under what circumstances. HHS builds evidence through evaluation and analysis in order to inform decisions in budget, legislative, regulatory, strategic planning, program, and policy arenas. Given the breadth of work supported by HHS, ma

ASPE leads a cross-departmental work group that collaboratively addresses issues around evidence and evaluation with the following goals:

The Division of Health Care Financing Policy (HFP) is responsible for research, policy analysis and evaluation of HHS’s health financing programs, primarily Medicare, and policies affecting health care financing, delivery system reform and health care costs. Relevant topic areas include:

The Division of Public Health Services (PHS) is responsible for public health services programs and policies. PHS works with Departmental components, particularly those that fund the provision of direct care to vulnerable populations, including primary care, clinical preventive services, and related support services. These include the Health Res

The Division of Health Care Quality and Outcomes (HQO) is responsible for analysis, coordination, research, and evaluation of policies related to health care quality and outcomes. HQO’s responsibilities include long-range planning, data development and analysis, program oversight, analysis of regulations and legislation, review and conduct of

Alzheimer’s disease (AD) is an irreversible, progressive brain disease that affects as many as 5.1 million Americans. It slowly destroys brain function, leading to:

Dear Mr. Tozzi Your request for reconsideration under the National Institutes of Health Guidelines for Ensuring the Quality of Information Disseminated to the Public, submitted on behalf of the Center for Regulatory Effectiveness is still under review. While our goal is to respond within 60 days to such requests, we are unable to do so in this c

The U.S. Department of Health and Human Services 200 Independence Avenue, S.W. Washington, D.C. 20201 Food and Drug Administration (FDA) Office of the Ombudsman Food and Drug Administration 5600 Fishers Lane Room 14B03, HF-7 Rockville, MD 20857 The Office of Management and Budget 725 17th Street, NW Washington, DC 20503 Subject: Request

Dear Mr. Cook: Thank you for your May 31, 2006, Request for Correction of Information under the National Institutes of Health (NIH) Guidelines for Ensuring the Quality of Information Disseminated to the Public. This office received your request on April 3, 2006.  We also received your July 13, 2006 and July 17, 2006 addendums on July 26, 2006

Dear Mr. Cook: Your request for reconsideration under the National Institutes of Health Guidelines for Ensuring the Quality of Information Disseminated to the Public, submitted on behalf of the Chemical Products Corporation, is still under review.  While our goal is to respond within 60 days to such requests, we are unable to do so in this case

Dear Mr. Cook: Your request for reconsideration under the National Institutes of Health Guidelines for Ensuring the Quality of Information Disseminated to the Public, submitted on behalf of the Chemical Products Corporation, is still under review.  While our goal is to respond within 60 days to such requests, we are unable to do so in this case

Dear Mr. Cook: Your request for reconsideration under the National Institutes of Health Guidelines for Ensuring the Quality of Information Disseminated to the Public, submitted on behalf of the Chemical Products Corporation, is still under review. While our goal is to respond within 60 days to such requests, we are unable to do so in this case.

Dear Mr. Cook: Your request for reconsideration under the National Institutes of Health Guidelines for Ensuring the Quality of Information Disseminated to the Public, submitted on behalf of the Chemical Products Corporation, is still under review. While our goal is to respond within 60 days to such requests, we are unable to do so in this case.

US data on influenza deaths are false and misleading. The Centers for Disease Control and Prevention (CDC) acknowledges a difference between flu death and flu associated death yet uses the terms interchangeably. Additionally, there are significant statistical incompatibilities between official estimates and national vital statistics data. Compound